Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M. Reduction of
intraocular pressure and glaucoma progression: results from the Early Manifest
Glaucoma Trial.Arch Ophthalmol. 2002;120(10):1268-1279.
Higginbotham EJ, Schuman JS, Goldberg I, Gross RL, VanDenburgh AM, Chen K,
Whitcup SM for the Bimatoprost Study Groups 1 and 2. One-year, randomized study
comparing bimatoprost and timolol in glaucoma and ocular hypertension. Arch
Ophthalmol. 2002 Oct;120(10):1286-93.
Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment
Study: a randomized trial determines that topical ocular hypertensive
medication delays or prevents the onset of primary open-angle glaucoma. Arch
Ophthalmol. 2002;120:701-713.
Sommer A, Katz J, Quigley HA, et al. Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss. Arch Ophthalmol. 1991;109(1):77-83.
The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The
relationship between control of intraocular pressure and visual field
deterioration. Am J Ophthalmol. 2000;130(4):429-440.
Noe G, Ferraro J, Lamoureux E, Rait J, Keeffe JE. Associations between glaucomatous visual field loss and participation in activities of daily living. Clin Experiment Ophthalmol. 2003 Dec;31(6):482-6.
Hoste AM. New insights into the subjective perception of visual field defects. Bull Soc Belge Ophtalmol. 2003;(287):65-71.
Nelson P, Aspinall P, Papasouliotis O, Worton B, O'Brien C. Quality of life in glaucoma and its relationship with visual function. J Glaucoma. 2003 Apr;12(2):139-50.
Nelson P, Aspinall P, O'Brien C. Patients' perception of visual impairment in glaucoma: a pilot study. Br J Ophthalmol. 1999 May;83(5):546-52.
Butler RN, Faye EE, Guazzo E, Kupfer C. Keeping an eye on vision: primary care of age-related ocular disease. Part 1. Geriatrics. 1997 Aug;52(8):30-41.
Herndon JG, Helmick CG, Sattin RW, Stevens JA, DeVito C, Wingo PA. Chronic medical conditions and risk of fall injury events at home in older adults. J Am Geriatr Soc. 1997 Jun;45(6):739-43.
Ivers RQ, Cumming RG, Mitchell P, Attebo K. Visual impairment and falls in older adults: the Blue Mountains Eye Study J Am Geriatr Soc. 1998 Jan;46(1):58-64.
Kerrigan-Baumrind LA, Quigley HA, Pease ME, Kerrigan DF, Mitchell RS. Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Invest Ophthalmol Vis Sci. 2000;41(3):741-748.
Knudtson MD, Klein BE, Klein R, Cruickshanks KJ, Lee KE. Age-related eye disease, quality of life, and functional activity. Arch Ophthalmol. 2005 Jun;123(6):807-14.
Owsley C, McGwin G Jr, Ball K. Vision impairment, eye disease, and injurious motor vehicle crashes in the elderly. Ophthalmic Epidemiol. 1998 Jun;5(2):101-13.
Quigley HA, Addicks EM, Green WR. Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy. Arch Ophthalmol. 1982;100(1):135-146.
Szlyk JP, Mahler CL, Seiple W, Edward DP, Wilensky JT. Driving performance of glaucoma patients correlates with peripheral visual field loss. J Glaucoma. 2005 Apr;14(2):145-50.
|